Nanomedicine News

RSS

New Nanowires-Filled Electric Mesh Device Holds Promise in Improving Heart Function During Heart Failure

A team of researchers guided by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Seoul National University have created a novel electric mesh device. This device is designed to be wrapped around the heart to convey electrical impulses such that cardiac function can be enhanced in trial models of heart failure.

29 Jun 2016

New Nanomachines with Potential to Impact Real-World Medical Applications

Think of constructing a complex work of architecture such as a castle. Now imagine if when all its individual parts are gathered together, the castle automatically begins to assemble by itself. Stretch that imagination by scaling down the size of this castle to be a size so small that it has to be measured on the same scale as viruses, DNA, and small molecules.

28 Jun 2016

Synergy between Nanotechnology and Math can Lead to Improvement in Cancer Therapy

In the struggle against cancer treatment resistance, nanotechnology, math, and biology are becoming strange, yet effective. An innovative approach towards cancer treatment that pits a deadly mixture of drugs together into a sole nanoparticle, has been engineered by the University of Waterloo and Harvard Medical School scientists.

27 Jun 2016

UT’s NanoLab Performs Real Life Brain Studies

The standard Petri dish comprising of flat electrodes is deemed to be insufficient to study the working of brain cells and also to assess the impact of medication on separate cells. Cells are expected to increase within three-dimensional surroundings as far as realistic studies are concerned.

24 Jun 2016

World Scientific's New Book Highlights Advances, Challenges in Development of Nanotheranostics for Personalized Medicine

Nanomedicines demonstrate the capability to enhance drug properties by offering protection from degradation, enabling controlled release and biodistribution and increasing bioavailability.

24 Jun 2016

Cerulean Doses First Patient in Phase 1/2a Study of Tumor-Targeted Nanoparticle-Drug Conjugate

Cerulean Pharma Inc., a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that the first patient has been dosed in the Phase 2a stage of an ongoing Phase 1/2a clinical trial of CRLX301 in patients with advanced solid tumors.

24 Jun 2016

Researchers Produce Novel Drug that is Safer and Efficiently Dissolves Blood Clots

One of the primary health concerns worldwide are the critical conditions caused by the blockage of blood vessels. The main aim for emergency assistance during the onset of such conditions is to efficiently implement thrombolysis - dissolving the clot quickly. ITMO University researchers in collaboration with Mariinsky Hospital in Saint Petersburg have created a magnetically controlled drug that could condense on a blood clot due to the presence of a magnetic field.

24 Jun 2016

Self-Assembling Protein Nano-Cages Could Carry Cargo into Living Cells

In the last century, a 20-sided solid was morphed into geodesic domes. This solid is likely to play a major role in synthetic biology. The geometry of the icosahedron is inspiring a team of researchers from the University of Washington Institute of Protein Design who are involved in inventing vehicles, molecular tools, and devices for medicine and other fields.

23 Jun 2016

New Nanoparticle Based Treatment Platform Developed to Treat Deadly Thyroid Cancer

Anaplastic thyroid cancer (ATC) is a highly life threatening form of thyroid cancer with a mortality rate of nearly 100% and an average survival time of three to five months. One promising approach to treat this type of cancer and others is RNA interference (RNAi) nanotechnology. However delivery of RNAi agents to the precise area of the tumor has been a struggle.

22 Jun 2016

New Nanocapsules Cure Majority of Parasite-Infected Mice

Lychnopholide, a substance isolated from a Brazilian plant, and formulated as part of "nanocapsules" cured more than half of a group of mice that had been infected experimentally with Chagas disease parasites.

21 Jun 2016

Nanomedicine News

New Nanowires-Filled Electric Mesh Device Holds Promise in Improving Heart Function During Heart Failure

New Nanomachines with Potential to Impact Real-World Medical Applications

Synergy between Nanotechnology and Math can Lead to Improvement in Cancer Therapy

UT’s NanoLab Performs Real Life Brain Studies

World Scientific's New Book Highlights Advances, Challenges in Development of Nanotheranostics for Personalized Medicine

Cerulean Doses First Patient in Phase 1/2a Study of Tumor-Targeted Nanoparticle-Drug Conjugate

Researchers Produce Novel Drug that is Safer and Efficiently Dissolves Blood Clots

Self-Assembling Protein Nano-Cages Could Carry Cargo into Living Cells

New Nanoparticle Based Treatment Platform Developed to Treat Deadly Thyroid Cancer

New Nanocapsules Cure Majority of Parasite-Infected Mice

Green Synthesis of Silver Nanoparticles Using Pomegranate Peel Extract

Breakthrough Nano Material Uses Sunlight to Tackle Pollution and Produce Energy

Building a Quantum Model with Nanoscale Carbon Molecules

Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis

Nanotechnology Could Improve Odds in Treating Aggressive Breast Cancers

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting

Why is 316L Stainless Steel Important for Production?